BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen K, Kempfle JS, Jung DH, Mckenna CE. Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015). Expert Opinion on Therapeutic Patents 2017;27:191-202. [DOI: 10.1080/13543776.2017.1252751] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Plontke SK. Diagnostics and therapy of sudden hearing loss. GMS Curr Top Otorhinolaryngol Head Neck Surg 2017;16:Doc05. [PMID: 29503670 DOI: 10.3205/cto000144] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
2 Glueckert R, Johnson Chacko L, Rask-Andersen H, Liu W, Handschuh S, Schrott-Fischer A. Anatomical basis of drug delivery to the inner ear. Hear Res 2018;368:10-27. [PMID: 30442227 DOI: 10.1016/j.heares.2018.06.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
3 Wichova H, Alvi S, Boatright C, Ledbetter L, Staecker H, Lin J. High-Resolution Computed Tomography of the Inner Ear: Effect of Otosclerosis on Cochlear Aqueduct Dimensions. Ann Otol Rhinol Laryngol 2019;128:749-54. [PMID: 30971097 DOI: 10.1177/0003489419842579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Schilder AG, Su MP, Mandavia R, Anderson CR, Landry E, Ferdous T, Blackshaw H. Early phase trials of novel hearing therapeutics: Avenues and opportunities. Hearing Research 2019;380:175-86. [DOI: 10.1016/j.heares.2019.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
5 Musazzi UM, Franzé S, Cilurzo F. Innovative pharmaceutical approaches for the management of inner ear disorders. Drug Deliv Transl Res 2018;8:436-49. [PMID: 28462501 DOI: 10.1007/s13346-017-0384-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
6 Scheper V, Hoffmann A, Gepp MM, Schulz A, Hamm A, Pannier C, Hubka P, Lenarz T, Schwieger J. Stem Cell Based Drug Delivery for Protection of Auditory Neurons in a Guinea Pig Model of Cochlear Implantation. Front Cell Neurosci 2019;13:177. [PMID: 31139049 DOI: 10.3389/fncel.2019.00177] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
7 Salt AN, Plontke SK. Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications. Hear Res 2018;368:28-40. [PMID: 29551306 DOI: 10.1016/j.heares.2018.03.002] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 14.0] [Reference Citation Analysis]
8 Mohammed Y, Holmes A, Kwok PCL, Kumeria T, Namjoshi S, Imran M, Matteucci L, Ali M, Tai W, Benson HAE, Roberts MS. Advances and future perspectives in epithelial drug delivery. Adv Drug Deliv Rev 2022;186:114293. [PMID: 35483435 DOI: 10.1016/j.addr.2022.114293] [Reference Citation Analysis]
9 Geissler C, Blumenstock M, Gabrielpillai J, Guchlerner L, Stöver T, Diensthuber M. Simultaneous treatment with pentoxifylline does not adversely affect the neurotrophic effects of brain-derived neurotrophic factor on spiral ganglion neurons. Neuroreport 2021;32:1134-9. [PMID: 34284444 DOI: 10.1097/WNR.0000000000001701] [Reference Citation Analysis]
10 Jung DH, Rauch SD. Clinical trials for inner ear drugs: Design and execution challenges. Hear Res 2018;368:123-6. [PMID: 29602591 DOI: 10.1016/j.heares.2018.03.020] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Liu X, Li M, Smyth H, Zhang F. Otic drug delivery systems: formulation principles and recent developments. Drug Dev Ind Pharm 2018;44:1395-408. [PMID: 29659300 DOI: 10.1080/03639045.2018.1464022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
12 Zhang Z, Li X, Zhang W, Kohane DS. Drug Delivery across Barriers to the Middle and Inner Ear. Adv Funct Mater 2021;31:2008701. [PMID: 34795553 DOI: 10.1002/adfm.202008701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
13 Kempfle JS, Nguyen K, Hamadani C, Koen N, Edge AS, Kashemirov BA, Jung DH, McKenna CE. Bisphosphonate-Linked TrkB Agonist: Cochlea-Targeted Delivery of a Neurotrophic Agent as a Strategy for the Treatment of Hearing Loss. Bioconjug Chem 2018;29:1240-50. [PMID: 29485861 DOI: 10.1021/acs.bioconjchem.8b00022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
14 Basch CH, Yin J, Kollia B, Adedokun A, Trusty S, Yeboah F, Fung IC. Public online information about tinnitus: A cross-sectional study of YouTube videos. Noise Health 2018;20:1-8. [PMID: 29457600 DOI: 10.4103/nah.NAH_32_17] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Gheorghe DC, Niculescu AG, Bîrcă AC, Grumezescu AM. Nanoparticles for the Treatment of Inner Ear Infections. Nanomaterials (Basel) 2021;11:1311. [PMID: 34067544 DOI: 10.3390/nano11051311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Hao J, Li SK. Inner ear drug delivery: Recent advances, challenges, and perspective. European Journal of Pharmaceutical Sciences 2019;126:82-92. [DOI: 10.1016/j.ejps.2018.05.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 13.0] [Reference Citation Analysis]
17 Bodmer D. An update on drug design strategies to prevent acquired sensorineural hearing loss. Expert Opin Drug Discov 2017;12:1161-7. [PMID: 28838250 DOI: 10.1080/17460441.2017.1372744] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]